Medifast Reports Q3 Revenue of $72 Million, Guides Q4 EPS
Medifast reported Q3 2026 revenue of $72.0 million, down 19% year over year, and a net loss of $17.5 million, or $1.57 per share. It forecast Q4 2026 revenue of $55 million to $75 million and EPS of $0.00 to $0.25, with profitability expected.